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Researchers work across disciplines  
to end COVID-19 pandemic  
By Erin Pennington and Jennifer Tidball
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When the world paused during the COVID-19 pandemic, many Kansas 
State University researchers did the opposite. 
K-State researchers increased their efforts or pivoted focus to join the 
battle against the novel coronavirus. By February 2021 — nearly a year 
after the World Health Organization declared the COVID-19 pandemic 
— K-State had more than $35 million in coronavirus-related grant 
proposals, more than $12 million in contracts for COVID-19 research 
and several new technologies licensed to corporate partners to combat 
the disease. 
Research across the university has ranged from treatment and vaccine 
development to understanding the pandemic’s effects on early learners. 
Read more about the variety of K-State projects during the pandemic.  
Candidate compound
A series of protease inhibitors developed, patented and licensed by 
K-State continues to help the fight against coronaviruses, including 
SARS-CoV-2, the virus that causes COVID-19. Cocrystal Pharma 
Inc., a clinical-stage biotechnology company, has selected the protease 
inhibitors as a preclinical lead compound for further development. 
Kyeong-Ok “KC” Chang and Yunjeong Kim, virologists in the K-State 
College of Veterinary Medicine, developed the protease inhibitors in 
collaboration with William Groutas at Wichita State University and 
Stanley Perlman at the University of Iowa. K-State Innovation Partners 
licensed the protease inhibitors, which could lead to a possible COVID-
19 drug or treatment.  
“Further studies are required to reveal the therapeutic potency of our 
protease inhibitor compared to other approved drugs,” Kim said. “Drugs 
targeting different virus proteins are often combined to maximize their 
efficacy, so it is always nice to have a repertoire of drugs that work in 
different ways.” 
Preclinical animal studies of these K-State coronavirus compounds 
published in the prestigious medical journal Science Translational 
Medicine showed efficacy against Middle East respiratory syndrome, or 
MERS, a related deadly human coronavirus infection, in a mouse model. 
Further testing allowed Cocrystal to identify this promising candidate 
for preclinical lead development for COVID-19. According to the 
company, the compound potentially could be delivered through injection 
or inhalation and could be used as both a therapeutic and prophylactic, which protects uninfected 
individuals who may become exposed.
With the selection of this candidate, Cocrystal will initiate studies to evaluate potential toxicity risks 
and conduct safety pharmacology studies before the phase 1 clinical trial.
Virologists Yunjeong Kim, left, and Kyeong-Ok “KC” Chang have developed a series of 
protease inhibitors.
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Developing the research space
K-State recently received a $1.2 million University 
SARS-CoV-2/COVID Research and Diagnostic Capacity 
Support Grant from the Kansas Department of 
Commerce as part of the Coronavirus Aid, Relief and 
Economic Security Act — known as the CARES Act — 
distribution. These funds will launch a Biotechnology 
Development Module, or BDM, at the K-State 
Biosecurity Research Institute, or BRI.
The National Bio and Agro-Defense Facility, or NBAF 
— nearing completion adjacent to K-State’s Manhattan 
campus — will house a BDM for companies to increase 
manufacturing for a limited number of select agent 
countermeasures. The K-State BDM at the BRI will be a 
complementary pilot-scale facility for research that does 
not focus only on NBAF-priority diseases.  
Environmental stability
K-State researchers are helping understand how long SARS-CoV-2 can 
survive on different types of surfaces and in various temperatures.
A Center of Excellence for Emerging and Zoonotic Animal Diseases, 
or CEEZAD, team recently completed a BRI study on the topic. The 
researchers, also from the College of Veterinary Medicine, included 
Taeyong Kwon, doctoral student in pathobiology; Natasha Gaudreault, 
research assistant professor of diagnostic medicine and pathobiology; 
and Jürgen A. Richt, Regents distinguished professor and CEEZAD 
director.
The study resulted in several important insights into SARS-CoV-2 
survival, including: 
 » The virus survived the longest — 21 days after contamination — on 
surfaces under winter conditions. 
 » In spring and fall conditions, the virus survived up to seven days. 
 » No infectious virus was found three days after contamination under 
summer conditions.
 » Under indoor conditions, infectious virus was recovered from 
cloth up to one day after contamination; for up to three days from 
concrete, polypropylene, stainless steel and galvanized steel; and for 
up to four days from nitrile gloves, Tyvek, N95 masks, Styrofoam, 
cardboard, rubber and glass.
“These findings clarify a major concern among scientists, and also 
among members of the general public, namely the ability of the SARS-
CoV-2 to survive on various surfaces under varying climatic conditions,” 
Richt said. “It shows that the virus’s ability to remain a threat is greatest 
in winter and less in summer. But it also shows that even in indoor 
conditions, SARS-CoV-2 remains viable for several days depending on 
the surface.”
The K-State BDM will allow researchers and corporate 
partners to develop diagnostic, therapeutic and preventive 
countermeasures for a broad range of emerging zoonotic 
diseases, including SARS-CoV-2 and African swine 
fever virus. The facility will be located in unique close 
proximity to containment and non-containment animal 
facilities as well as the Kansas State Veterinary Diagnostic 
Laboratory. 
“K-State’s strengths in addressing threats to plant, animal 
and human health are more important than ever before,” 
said Beth Montelone, interim vice president for research. 
“This grant will enable K-State to continue to grow its 
vaccine and other countermeasure development strategy 
to address new and emerging diseases.”
 A Biotechnology Development Module at the Biosecurity 
Research Institute will allow research on emerging 
pathogens. 
A K-State study focuses on how long the SARS-CoV-2 
virus survives in different climates and on different 
surfaces, such as gloves, masks, glass and cardboard.
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Understanding quarantine
Kyle Goerl, medical director of K-State’s Lafene Health 
Center, is part of a collaborative team providing research-
based guidance during the COVID-19 pandemic. The 
Centers for Disease Control and Prevention has used 
the team’s research to update and shorten quarantine 
guidance.
Goerl is a co-author of a quarantine-related publication 
that recently appeared in the CDC Morbidity and 
Mortality Weekly Report and involved multiple 
organizations and universities.
The publication describes a sample of COVID-19-
exposed collegiate athletes in 17 states from June to 
October 2020. Twenty-five percent of the athletes tested 
positive during quarantine and the positive test occurred 
an average of 3.8 days after quarantine started. As 
quarantine progressed, the probability of testing positive 
dropped from 27% after day five to less than 5% after 
day 10.
“These findings show that after 10 days of quarantine, 
the risk of COVID-19 is relatively low,” said Goerl, also 
a team physician for Kansas State University Athletics. 
“This helps to support a quarantine period that is shorter 
than 14 days. If the quarantine period is shortened, it is 
more likely that people will follow important quarantine 
measures.”
Effect on early learners
Adelaide Klutse, master’s student in applied family 
science in the College of Health and Human Sciences, 
is studying how teachers are facilitating the social-
emotional development of children ages 0 through 5 
during the COVID-19 pandemic. 
Her research is providing knowledge on the availability 
and kinds of support targeted at empowering early 
educators during the pandemic.
Klutse is working with adviser Bradford Wiles, associate 
professor of applied human sciences, to understand 
how teachers facilitate social-emotional development in 
children when close contact and touch are major risks 
for disease transmission. She is researching how teachers’ 
perceived levels of stress affect their classroom qualities 
and their abilities to help children with social-emotional 
development. 
According to Klutse, this study is significant because 
current research does not include early childhood 
education teachers who are facilitating development in 
the early years. 
“Research suggests children spend a considerable number 
of hours with their teachers and these teachers’ abilities 
to facilitate socioemotional development in children 
goes a long way toward influencing family outcomes in 
current and future families,” Klutse said. 
By the numbers  
K-State COVID-19 research 
Analyzing contact tracing 
K-State engineers are investigating some of the hidden 
mechanisms behind the spread of COVID-19. 
In their latest work, the researchers in the Carl R. Ice 
College of Engineering are modeling the spread of 
COVID-19 and evaluating the effectiveness of disease 
mitigation measures. Specifically, they have studied the 
benefits and costs of contact tracing and how effective it 
is in containing the spread of COVID-19. 
“Contact tracing plays a vital role as a critical mitigation 
strategy for COVID-19,” said Sifat Afroj Moon, doctoral 
student in electrical and computer engineering. “Our 
investigation indicates that a sufficient amount of contact 
tracing can reduce the impact of COVID-19 spreading in 
the reopening process of a location.”
Moon works with Caterina Scoglio, the LeRoy and 
Aileen Paslay professor and Steve Hsu Keystone research 
scholar in the Mike Wiegers Department of Electrical 
and Computer Engineering. They recently published their 
findings on contact tracing in Nature Scientific Reports. 
The researchers are continuing their modeling research 
and also are studying and simulating the effectiveness of 
multiple COVID-19 vaccination strategies. 
Kyle Goerl, K-State medical director, is helping provide 
research-based quarantine guidance.
Adelaide Klutse, master’s student in applied family 
science, is studying how children are adapting during  
the pandemic.
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